Arcosa, Inc. is 3.4x more valuable than Proto Labs Inc by market capitalization ($6.23 B vs $1.84 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PRLB | ACA |
|---|---|---|
| Market cap | $1.84 B | $6.23 B |
| US-listed rank | #2164 | #1249 |
| Revenue (latest FY) | $533.13M | $2.88B |
| Net income (latest FY) | $21.24M | $208.40M |
| Net margin | 4.0% | 7.2% |
| P/E (trailing FY) | 86.5 | 29.9 |
| SEC filings | 878 | 632 |
Arcosa, Inc. is 3.4x more valuable than Proto Labs Inc by market capitalization ($6.23 B vs $1.84 B).
In their latest fiscal years, Proto Labs Inc reported $533.13M in revenue while Arcosa, Inc. reported $2.88B.
Full pages: Proto Labs Inc and Arcosa, Inc., or browse the full rankings.